Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
USA118th CongressHR-5027| House
| Updated: 12/17/2024
Carol D. Miller
Republican Representative
West Virginia
Cosponsors (13)
Terri A. Sewell (Democratic)Steve Cohen (Democratic)Frank J. Mrvan (Democratic)Raja Krishnamoorthi (Democratic)Jerrold Nadler (Democratic)Alma S. Adams (Democratic)Eleanor Holmes Norton (Democratic)Joe Neguse (Democratic)Michelle Steel (Republican)Yvette D. Clarke (Democratic)Yadira Caraveo (Democratic)Susan Wild (Democratic)Vern Buchanan (Republican)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Timeline
Bill from Previous Congress
HR 116-3912Chronic Kidney Disease Improvement in Research and Treatment Act
Bill from Previous Congress
HR 117-4065Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Health
Advanced technology and technological innovationsCongressional oversightDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care coverage and accessHealth personnelHealth promotion and preventive careHealth technology, devices, suppliesHigher educationMedical researchMedical tests and diagnostic methodsMedicareNational and community servicePrescription drugsStudent aid and college costs
Chronic Kidney Disease Improvement in Research and Treatment Act of 2023
USA118th CongressHR-5027| House
| Updated: 12/17/2024
Timeline
Bill from Previous Congress
HR 116-3912Chronic Kidney Disease Improvement in Research and Treatment Act
Bill from Previous Congress
HR 117-4065Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
Introduced in House
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Carol D. Miller
Republican Representative
West Virginia
Cosponsors (13)
Terri A. Sewell (Democratic)Steve Cohen (Democratic)Frank J. Mrvan (Democratic)Raja Krishnamoorthi (Democratic)Jerrold Nadler (Democratic)Alma S. Adams (Democratic)Eleanor Holmes Norton (Democratic)Joe Neguse (Democratic)Michelle Steel (Republican)Yvette D. Clarke (Democratic)Yadira Caraveo (Democratic)Susan Wild (Democratic)Vern Buchanan (Republican)
Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Advanced technology and technological innovationsCongressional oversightDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care coverage and accessHealth personnelHealth promotion and preventive careHealth technology, devices, suppliesHigher educationMedical researchMedical tests and diagnostic methodsMedicareNational and community servicePrescription drugsStudent aid and college costs